HIV-Prevention Education for University Student Health Centers

Meeting Slides

Clinical Practice Guidelines

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents.

US Department of Health and Human Services, revised 2018.

Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living With HIV.

US Department of Health and Human Services, last updated May 30, 2018.

Preexposure Prophylaxis for the  Prevention of HIV Infection in the United States—2017 Update. Clinical Provider’s Supplement

Centers for Disease Control and Prevention, 2017.

Quick Reference Guide: Recommended Laboratory HIV Testing Algorithm for Serum or Plasma Specimens.

Centers for Disease Control and Prevention, 2018.

STD and HIV Screening Recommendations.

Centers for Disease Control and Prevention, 2017.

Clinical Resources

American Academy of HIV Medicine | Supporting the HIV Care Provider and the Profession.

Basic Statistics.

Centers for Disease Control and Prevention, July 2018.

Brief Sexual History Tool.

Centers for Disease Control and Prevention.

Database of Antiretroviral Drug Interactions.

HIV InSite. University of California, San Francisco.

Effectiveness of Prevention Strategies to Reduce the Risk of Acquiring or Transmitting HIV.

Centers for Disease Control and Prevention, 2017.

HIV Among Youth.

Centers for Disease Control and Prevention, 2018.

HIV Drug Interactions.

University of Liverpool (Web site), 2017.

HIV in the United States by Region.                                       

Centers for Disease Control and Prevention, 2017.

HIV Surveillance Supplemental Report.

Centers for Disease Control and Prevention, 2018.

HIV Surveillance Fact Sheet, Georgia, 2015.

Georgia Department of Public Health, April 2017. 

National College Health Assessment II.

American College Health Association, 2013.

PrEP Kit.

AIDS United, 2015.

Provider Information Sheet: PrEP During Conception, Pregnancy, and Breastfeeding.                                        

Centers for Disease Control and Prevention.

Sexually Transmitted Diseases Treatment Guidelines.

Centers for Disease Control and Prevention, 2015.

State HIV Laws.

Centers for Disease Control and Prevention, 2018.

Taking a Sexual History.

NYC Health, 2015.

Transgender Health Learning Center.

University of California, San Francisco, 2018.

Partner Organizations

Above the Status Quo

Georgia AIDS Education and Training Center

Patient Resources

Centers for Disease Control and Prevention (CDC): HIV Basics.

The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This comprehensive site provides extensive links to topics across the HIV-care continuum, including preexposure prophylaxis (PrEP).

HIV Risk Reduction Tool.

Centers for Disease Control and Prevention.

Pill-Reminder Smartphone Apps (Free)

Mango Health – Medicine Reminder and Manager for iPhone.

Mango Health for Android.

Medisafe Medicine Reminders & Tracker for iPhone.

Medisafe Pill Reminder & Medication Tracker for Android.

Positively Aware.

Positively Aware, created by TPAN (Test Positive Aware Network), is a source of HIV-treatment news for consumers, as well as an educational tool for HIV caregivers. The site features PrEP resources, including videos for men who have sex with men and transgender people.

PrEP for U.S. Women: A Collection of Resources.

HIVE provides preconception and prenatal care and resources for women and couples affected by HIV 

Suggested Readings

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.

Benefit of continuous/immediate ART on disease risk: SMART & START combined analysis.

Borges AH, et al. 24th Conference on Retroviruses and Opportunistic Infections; February 13−16, 2017; Seattle, WA. Abstract 474.

Frequency of HIV testing and time from infection to diagnosis improve.

Centers for Disease Control and Prevention, 2017.

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.

Being PrEPared – preexposure prophylaxis and HIV disparities.

Goldstein RH, et al. N Engl J Med. 2018;379(14):1293-1295

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant RM, et al. N Engl J Med. 2010;363(27):2587-2599.

Challenges in translating PrEP interest into uptake in an observational study of young black MSM.

Rolle CP, et al. J Acquir Immun Defic Syndr. 2017;76(3):250-258.

Willingness to use pre-exposure prophylaxis among black and white men who have sex with men in Atlanta, Georgia.

Rolle CP, et al. Int J STD AIDS. 2017;28(9):849-857.

Initiation of antiretroviral therapy in early asymptomatic HIV infection.

The INSIGHT START Study Group. N Engl J Med. 2015;373(9):795-80.

Interactive Presentation

PrEP HIV Pre-Exposure Prophylaxis

Narrated by Raphael J. Landovitz, MD

Sexual History

Narrated by Raphael J. Landovitz, MD

Introducing PrEP and Determining Eligibility

Narrated by Raphael J. Landovitz, MD

Pre-PrEP Patient Education

Narrated by Raphael J. Landovitz, MD

PrEP Monitoring ond Ongoing Counseling

Narrated by Raphael J. Landovitz, MD


HIV-Prevention Education for University Student Health Centers

Relevant Resources

Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms

Individualized Management in Primary Care

Acute Management of Migraine Attacks

Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes

Clinical Updates on the Management of Gout

Evidence-Based Strategies for Improved Patient Outcomes

Opioid-Induced Constipation

Proactive Diagnosis and Targeted Management

Chronic Obstructive Pulmonary Disease, Asthma, or Both

Differential Diagnosis and Comprehensive Management Strategies

Improving Outcomes in Chronic Obstructive Pulmonary Disease

Optimizing Maintenance Therapy Across Healthcare Settings

Managing Gout in Primary Care

Evolving Strategies for Diagnosis and Long-Term Management

Clinical Issues in Chronic Pain

Consensus and Controversies for Responsible Opioid Prescribing

Noninsulin Approaches to Managing Type 2 Diabetes

Best Practices in Combination Therapy

Hitting the Target in Type 2 Diabetes

Evolving Approaches to Insulin Based Therapy

Clearing the Air

Improving Outcomes for Patients with COPD

Clinical Updates in Type 2 Diabetes

New Strategies for Insulin Replacement Therapy

How Low Do You Go?

Clinical Updates in LDL-C Management

Incretin-Based Therapies For Type 2 Diabetes

Improving Comprehensive Patient Care

Improving Outcomes in Non–24-Hour Sleep-Wake Disorder

Identifying Patients and Tailoring Therapy

Comprehensive Management of Chronic Obstructive Pulmonary Disease

Collaborative Approaches to Guideline-Concordant Patient Care

Clinical Updates in the Management of Severe Asthma

New Strategies for Individualizing Long-term Care

Comprehensive Chronic Pain Management

A Focus on Patients With Opioid-Induced Constipation

Clinical Issues in Bipolar Depression

Consensus and Controversies Across the Spectrum of Patient Presentations

Clinical Updates in Rheumatoid Arthritis

Evolving Treatment Algorithms and Expert Perspectives on Biosimilars

Caring for Patients with Severe Asthma

Evolving Best Practices to Optimize Outcomes

PrEP for Your Patients’ Needs

The PCPs Role in Preventing HIV

Can You Spot Axial Spondyloarthritis?

The PCP’s Role in Timely Recognition and Referral

Value-Based HIV Formularies

Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care

Hepatitis C is Curable

Got it? Treat it!

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist


Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.

Evolving Models of HIV Care

Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

Advancing the Care of Severe Asthma

Differential Diagnosis, Multidisciplinary Management, and Patient Engagement

Updates in HCV Screening and Treatment

Key Issues Impacting OB/GYN Practice

Clinical Issues in Chronic Liver Disease

Hot Topics in HBV, HCV, and NASH

Evolving Models of HIV Care

Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice

Assessing Your Patients for HCV and HIV

Why It Matters in OB/GYN Practice Today

Clearing the Air in Severe Asthma Management

Improving Patient Outcomes Through Shared Clinical Decision Making

HIV as a Chronic Disease

A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities

The Pursuit of Hepatitis C Elimination

How the Pharmacist Can Make a Difference

GLP-1 Receptors Agonists in Type 2 Diabetes

Mechanistic Insights and Evolving Treatment Options

Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

Understanding the Growing Syndemic — Opioids, HCV, and HIV

Airing It Out

A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis

COPD in Managed Care

The Clinical and Utilization Benefits of Exacerbation Prevention

Assimilating the Evidence in T2DM

Cardiovascular and Renal Outcomes With SGLT2 Inhibitors

Demystifying New Evidence for COPD Management

Best Practices for Primary Care

Finding Relief in Osteoarthritis

New Paths to Chronic Pain Management

Stepping Up to the Challenge

The PCP’s Role in HCV Elimination

The Changing Landscape of HIV Prevention

What the Pharmacist Needs to Know about PrEP

HIV Updates for Pharmacy Practice

Maximizing Your Role to Impact Patient Outcomes

Case Challenges in HIV Medicine

Benefits, Barriers, & Best Practices in an Advancing Field